131 related articles for article (PubMed ID: 27803168)
21. Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis models.
Chinnaratha MA; Jeffrey GP; MacQuillan G; Rossi E; de Boer BW; Speers DJ; Adams LA
Liver Int; 2014 May; 34(5):720-7. PubMed ID: 24034439
[TBL] [Abstract][Full Text] [Related]
22. The validity of serum markers for fibrosis staging in chronic hepatitis B and C.
Li J; Gordon SC; Rupp LB; Zhang T; Boscarino JA; Vijayadeva V; Schmidt MA; Lu M;
J Viral Hepat; 2014 Dec; 21(12):930-7. PubMed ID: 24472062
[TBL] [Abstract][Full Text] [Related]
23. The impact of competing risks on the observed rate of chronic hepatitis C progression.
Kim WR; Poterucha JJ; Benson JT; Therneau TM
Gastroenterology; 2004 Sep; 127(3):749-55. PubMed ID: 15362031
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden.
Büsch K; Waldenström J; Lagging M; Aleman S; Weiland O; Kövamees J; Duberg AS; Söderholm J
Scand J Gastroenterol; 2017 Jan; 52(1):61-68. PubMed ID: 27598393
[TBL] [Abstract][Full Text] [Related]
25. Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response.
Le AK; Zhao C; Hoang JK; Tran SA; Chang CY; Jin M; Nguyen NH; Yasukawa LA; Zhang JQ; Weber SC; Garcia G; Nguyen MH
Aliment Pharmacol Ther; 2017 Sep; 46(6):605-616. PubMed ID: 28766727
[TBL] [Abstract][Full Text] [Related]
26. Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C.
Hernández-Bartolomé Á; López-Rodríguez R; Borque MJ; González-Moreno L; Real-Martínez Y; García-Buey L; Moreno-Otero R; Sanz-Cameno P
World J Gastroenterol; 2016 Nov; 22(44):9744-9751. PubMed ID: 27956798
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of patients with chronic hepatitis C treated with α-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response.
Cordero-Ruiz P; Carmona-Soria I; Rodríguez-Téllez M; Caunedo-Alvarez A; Quezada-Pacheco RH; Flores-Cucho A; Romero-Gómez M; Vilches-Arenas Á
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):792-799. PubMed ID: 28445251
[TBL] [Abstract][Full Text] [Related]
28. Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C.
Bloom S; Kemp W; Nicoll A; Roberts SK; Gow P; Dev A; Bell S; Sood S; Kronborg I; Knight V; Lewis D; Lubel J
J Hepatol; 2018 Sep; 69(3):575-583. PubMed ID: 29709676
[TBL] [Abstract][Full Text] [Related]
29. Diabetes mellitus is a significant risk factor for the development of liver cirrhosis in chronic hepatitis C patients.
Li X; Gao Y; Xu H; Hou J; Gao P
Sci Rep; 2017 Aug; 7(1):9087. PubMed ID: 28831144
[TBL] [Abstract][Full Text] [Related]
30. Non-invasive evaluation of liver fibrosis in chronic hepatitis C.
Trifan A; Cojocariu C; Sfarti C; Singeap AM; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):135-8. PubMed ID: 23077885
[TBL] [Abstract][Full Text] [Related]
31. Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.
Gabr SA; Alghadir AH; Allam AA; Ajarem J; Al-Basher G; Abdel-Maksoud MA; Ghfar AA; Aboud A
Clin Interv Aging; 2016; 11():523-33. PubMed ID: 27217734
[TBL] [Abstract][Full Text] [Related]
32. Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis.
Söderholm J; Millbourn C; Büsch K; Kövamees J; Schvarcz R; Lindahl K; Bruchfeld A
J Hepatol; 2018 May; 68(5):904-911. PubMed ID: 29233630
[TBL] [Abstract][Full Text] [Related]
33. Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting.
Dhiman RK; Grover GS; Premkumar M; Taneja S; Duseja A; Arora S; Rathi S; Satsangi S; Roy A;
J Hepatol; 2019 Dec; 71(6):1076-1085. PubMed ID: 31325468
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for liver-related mortality in chronic hepatitis C patients: a deceased case-living control study.
Zeng QL; Feng GH; Zhang JY; Chen Y; Yang B; Huang HH; Zhang XX; Zhang Z; Wang FS
World J Gastroenterol; 2014 May; 20(18):5519-26. PubMed ID: 24833882
[TBL] [Abstract][Full Text] [Related]
35. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
36. The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort-study.
Innes H; McAuley A; Alavi M; Valerio H; Goldberg D; Hutchinson SJ
Hepatology; 2018 Jan; 67(1):97-107. PubMed ID: 28777874
[TBL] [Abstract][Full Text] [Related]
37. Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C.
Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
Clin Interv Aging; 2016; 11():327-34. PubMed ID: 27051280
[TBL] [Abstract][Full Text] [Related]
38. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
[No Abstract] [Full Text] [Related]
39. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C.
Verveer C; Zondervan PE; ten Kate FJ; Hansen BE; Janssen HL; de Knegt RJ
Liver Int; 2012 Apr; 32(4):622-8. PubMed ID: 22098684
[TBL] [Abstract][Full Text] [Related]
40. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
